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        Antigen-specifi  c T cell activation requires the 
interaction of TCRs with specifi  c peptide  –
  MHC (pMHC) complexes expressed on an 
APC. During their development, T cells are se-
lected for weak or rare interactions with self-
pMHC complexes presented in the thymus 
(  1  –  3  ), and mature T cells require the presence 
of self-pMHC complexes in the periphery to 
survive (  4  –  6  ). Recent data indicate that recog-
nition of self-pMHC complexes enhances rec-
ognition of antigenic pMHC ( 7  –  11  ). Endogenous 
peptides enhance antigen reactivity of naive 
CD4  +   T cells, such that interruption of T cell 
contact with self-pMHC ligands leads to a rapid 
decline in signaling and sensitivity to foreign 
antigens (  7  ). An eff  ect of endogenous peptides 
in contributing to CD4      T cell activation has 
been noted at low antigen concentrations (  8, 9  ). 
This led to a   “  pseudodimer  ”   model of T cell 
  activation, where CD4 acts as a bridge between 
two TCRs: one recognizing antigen and the 
other interacting with endogenous pMHC class 
II complexes (  9, 12, 13  ). 
  Recently, we found that the presence of 
endogenous (or exogenous) nonstimulatory 
peptides enhances the formation of conjugates 
between APCs and CD8      T cell hybridomas, 
and increases the antigen-induced interaction 
between CD8 and TCR (  10  ). However, work 
with naive and antigen-experienced CD8      T cells 
suggested a negligible eff  ect for endogenous 
peptides on antigen recognition (  14  ). In CD4      
T cells, only a subset of endogenous peptides aid 
in the recognition of antigen, suggesting that 
TCR recognizes endogenous pMHC (  9  ). In 
contrast, our studies using CD8      T hybridomas 
showed that each of the tested endogenous or 
exogenous nonstimulatory peptides was capable 
of this feat, and that CD8 became concentrated 
in the immunological synapse (IS) even without 
the infl   uence of antigen, suggesting that the 
CD8  –  pMHC interaction is responsible for the 
enhancing eff  ect of the endogenous pMHC 
(  10  ). Recent data confi  rm that the CD8 interac-
tion with nonstimulatory pMHC aids in recog-
nition of antigenic pMHC (  11  ). We proposed a 
  “  pre-concentration  ”   model for the role of en-
dogenous pMHC in aiding antigen recognition. 
In this view, CD8 plus associated Lck and 
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  T cells are extremely sensitive in their ability to fi  nd minute amounts of antigenic peptide 
in the midst of many endogenous peptides presented on an antigen-presenting cell. The 
role of endogenous peptides in the recognition of foreign peptide and hence in T cell 
activation has remained controversial for CD8     T cell activation. We showed previously 
that in a CD8     T cell hybridoma, nonstimulatory endogenous peptides enhance T cell sensi-
tivity to antigen by increasing the coreceptor function of CD8. However, others were not 
able to detect such enhancement in naive and activated CD8     T cells. Here, we show that 
endogenous peptides substantially enhance the ability of T cells to detect antigen, an effect 
measurable by up-regulation of activation or maturation markers and by increased effector 
function. This enhancement is most pronounced in thymocytes, moderate in naive T cells, 
and mild in effector T cells. The importance of endogenous peptides is inversely propor-
tional to the agonist activity of the stimulatory peptide presented. Unlike for CD4     T cells, 
the T cell receptor of CD8     T cells does not distinguish between endogenous peptides for 
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absence or presence of diff  erent nonstimulatory peptides, we 
used the mAb 25-D1.16 that specifi  cally binds to OVA, but 
not to the nonstimulatory peptides, in complex with K  b   (  21  ). 
Diff  erent peptides have diff  erent abilities to stabilize pMHC. 
Therefore, we titrated the diff  erent nonstimulatory peptides 
such that they would give equal K  b   levels (    25,000 molecules 
per cell). We titrated OVA such that in the presence of a non-
stimulatory peptide the total MHC density was kept at a con-
stant high level, whereas in the absence of any nonstimulatory 
peptide the total MHC density depended on the OVA-K  b   
amount, and therefore was lower than in the presence of a 
nonstimulatory peptide (except at the highest concentrations 
of OVA) (  10  ). The data from the T cell stimulation assays 
were plotted as a function of 25-D1.16 (anti  –  K  b  -OVA) stain-
ing intensity as measured by fl  ow cytometry. Any diff  erences 
between the groups in the OVA-K  b   dose response curves were 
therefore a result of the presence of the nonstimulatory peptide 
or increased MHC density per se. 
  In CD4      T cells only certain nonstimulatory peptides have 
been shown to enhance antigen recognition (  9  ), whereas our 
experiments showed that each of the nonstimulatory K  b  -bind-
ing peptides tested enhanced recognition as defi  ned by T cell-
APC couple formation, TCR endocytosis, and the induced 
TCR-CD8 interaction (  10  ). Therefore, it was of interest to 
validate our earlier fi  ndings in ex vivo CD8      T cell popula-
tions, and for other markers of T cell activation. We therefore 
used a nonstimulatory peptide derived from vesicular stomati-
tis virus (VSV) and a series of endogenous nonstimulatory pep-
tides (  17  ) assaying for CD69 up-regulation, an early marker for 
thymocyte or T cell activation through the TCR (  22  ). Simul-
taneous presentation of nonstimulatory peptides with agonist 
peptide was able to enhance CD69 up-regulation. After a 5-h 
stimulation, this was most clear in pre-selection DP thymo-
cytes (  Fig. 1   and Fig. S1, which is available at http://www.jem
.org/cgi/content/full/jem.20062610/DC1).   For naive CD8      
T cells, the percentage of CD69      cells did not change greatly, 
although the amount of CD69 on the cell surface was consid-
erably increased by the nonstimulatory peptides (  Fig. 1 H  ). 
The eff  ect of nonstimulatory peptides was more evident at 
earlier time points (see next section). CTLs already expressed 
some CD69, and neither the percentage of CD69      cells nor 
the amount of CD69 was substantially changed by the pres-
ence of the nonstimulatory peptides after 5 h of stimulation 
(but see below). Similar data have been obtained with four 
more endogenous peptides (unpublished data). Thus, the eff  ect 
of nonstimulatory peptides decreased during diff  erentiation. 
A similar phenomenon was observed for TCR endocytosis 
(unpublished data). Therefore, the extent to which nonstimu-
latory peptides enhance antigen recognition was dependent on 
the diff  erentiation status of the CD8      T cell. 
  Nonstimulatory peptides are most important in the early 
stages of antigen recognition 
  We have previously suggested that nonstimulatory peptides act 
by helping the TCR to fi  nd the antigenic pMHC by concen-
trating pMHC to the IS through interactions with CD8 (  10  ). 
pMHC are concentrated to the synapse as a result of the non-
cognate CD8  –  pMHC interaction. Higher concentration of 
pMHC would enhance the ability of TCR to fi  nd its ligand, 
and the high concentration of CD8 (plus Lck) would enhance 
signal transduction (  10  ). 
  These contrasting data suggest diff  erent roles for TCR in 
the recognition of endogenous pMHC by CD4      or CD8      
T cells. To try to understand these controversial observations, 
we studied the response of diff   erent T cell populations to 
APCs presenting either an agonist peptide alone or in combi-
nation with diff  erent nonstimulatory peptides. We observed that 
nonstimulatory peptides were most eff  ective in enhancing an-
tigen recognition of less diff  erentiated cells, such that their 
ability to enhance antigen recognition was most distinct in 
thymocytes, moderate in naive T cells, and mild in eff  ector 
T cells. The recognition of weak agonists was more dependent 
on nonstimulatory peptides than was recognition of strong 
agonists. All of the tested nonstimulatory peptides were able to 
enhance T cell activation by weak or strong agonists, contrary 
to a prediction of the pseudodimer model (  13  ) and suggesting 
that CD8      T cells do not require specifi  c TCR recognition of 
the nonstimulatory pMHC to use them to enhance sensitivity 
of antigen recognition. Therefore, there seems to be an im-
portant diff  erence between CD4      and CD8      T cells in their 
ability to take advantage of endogenous peptides. 
    RESULTS   
  Nonstimulatory peptide-induced enhancement 
of antigen recognition depends on the differentiation 
status of the T cell 
  We previously showed that nonstimulatory peptides en-
hanced antigen recognition by CD8      OT-I T cell hybrid-
omas when presented together with an agonist peptide (  10  ). 
To extend these fi  ndings to T cells proper, we analyzed up-
regulation of the activation marker CD69 on thymocytes, 
naive T cells, and eff  ector CD8  +   T cells. To investigate pre-
selection CD4     CD8      double-positive (DP) thymocytes, 
cells were isolated from the thymi of OT-I TCR transgenic 
  Tap1   KO mice, where development is arrested before posi-
tive selection (  15  ). Naive T cells were harvested from the 
lymph nodes of OT-I transgenic mice, and activated T cells 
were obtained from a short-term antigen-stimulated culture 
of ex vivo OT-I T cells. OT-I T cells specifi  cally recognize 
an OVA-derived peptide presented in the context of H-2K  b   
(K  b  ). A series of peptides that do not stimulate OT-I T cells 
in the context of K  b   has been characterized (  15  –  17  ). 
  To obtain APCs in which the only diff  erence is the pres-
ence or absence of nonstimulatory peptides, we used   Tap2  -
defi  cient RMA-S cells. These lack the ability to load most 
endogenous peptides onto their MHC class I molecules, re-
sulting in a cell surface level of MHC class I of     5% of the 
  Tap2        parental RMA cell line (  18  –  20  ). The addition of exog-
enous peptides at 29  °  C stabilizes pMHC complexes on the 
cell surface, which therefore present almost exclusively the 
particular peptide(s) added (  20  ). To compare T cell responses 
to RMA-S cells expressing diff  erent levels of K  b  -OVA in the JEM VOL. 204, October 29, 2007 
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tory peptide was strongest at early time points, but by 20 h even 
minute amounts of OVA peptide were able to induce CD69 
up-regulation so that any eff  ect of nonstimulatory peptide was 
undetectable. The eff  ect of nonstimulatory peptides faded faster 
in CTLs, being gone by 7 h. In thymocytes, there was an ob-
servable diff  erence in response in the presence or absence of 
nonstimulatory peptides even at 24 h. This fi  nding suggests that 
nonstimulatory pMHC complexes are most important in the 
early stages of recognition of agonist pMHC but that, given 
Therefore, we wondered whether giving the TCR a longer 
time to fi  nd antigenic pMHC would render the eff  ect of non-
stimulatory peptides negligible. We also wondered whether the 
eff  ect of endogenous peptides might be stronger at diff  erent 
time points after stimulation. We measured CD69 up-regu-
lation at 2, 7, and 20 h in naive T cells (  Fig. 2  ), CTLs (Fig. S2, 
A  –  C, available at http://www.jem.org/cgi/content/full/jem
.20062610/DC1), and pre-selection DP thymocytes (Fig. S2, 
D  –  F).   For the naive CD8      T cells, the eff  ect of the nonstimula-
  Figure 1.     Nonstimulatory peptides increase antigen recognition by T cells at different differentiation states. RMA-S cells were loaded with 
various amounts of OVA alone or OVA plus nonstimulatory peptide. The RMA-S cells were allowed to interact with thymocytes (A, D, and G), naive T cells 
(B, E, and H), or effector CTLs (C, F, and I) for 5 h. The cells were stained with anti-CD8 and anti-CD69, and the level of CD69 was assessed by fl  ow cytom-
etry. The results are shown as percentage of CD69      cells (A, B, and C) or as mean fl  uorescent intensity (MFI) of CD69 staining (D, E, and F) from CD8 gated 
cells at different OVA-K  b   concentrations. For thymocytes, the overall population behaves uniformly, and the graphs for MFI and percent CD69  hi   populations 
look similar. For naive cells, CD69 up-regulation is bimodal. However, in the presence of nonstimulatory peptide, the MFI of the CD69  hi   cells is higher than 
in the absence of nonstimulatory peptides, and therefore the two groups display bigger differences when presented as MFI as opposed to percent CD69  hi . 
Example histograms (G, H, and I) are shown for each of the cell subsets. In the histograms, the dashed lines correspond to thymocytes or T cells incubated 
with RMA-S cells without added peptide, the dotted lines to cells incubated with RMA-S cells loaded with OVA alone, and the solid black lines to cells 
incubated with RMA-S cells loaded with OVA together with a large excess of the nonstimulatory VSV peptide. The example histograms have been chosen 
in such a way that the OVA-alone group displays more antigen than the group with the nonstimulatory peptide. (Fig. S1 shows an OVA-K  b  – matched 
comparison.) The results are representative of at least three independent experiments.     2750 ENHANCEMENT OF T CELL ACTIVATION BY ENDOGENOUS   P  MHC | Yachi et al.
a direct indicator of TCR engagement, both Q4 and T4 were 
weaker ligands than OVA (  Fig. 3 C  ). The presence of the non-
stimulatory peptide VSV resulted in enhanced CD25 up-regu-
lation by both Q4 and T4, whereas the eff  ect on OVA-induced 
CD25 up-regulation was almost negligible (  Fig. 3 A  ). Increased 
up-regulation of CD69 in the presence of nonstimulatory pep-
tides was seen with both APLs; the enhancement was the most 
pronounced for the weakest ligand, T4 (  Fig. 3 B  ). In addition, the 
presence of nonstimulatory peptide during recognition of OVA 
and both APLs enhanced TCR down-regulation on OT-I 
CTL, with the eff  ect being small for OVA, stronger for Q4, and 
strongest for T4 (  Fig. 3 C  ). Therefore, nonstimulatory peptides 
are more important in the recognition of weaker agonists. 
  Nonstimulatory peptides enhance antigen recognition equally 
well regardless of the agonist strength 
  A prediction of the pseudodimer model for T cell activation 
is that as the half-life of TCR for agonist decreases, a smaller 
subset of the available endogenous peptides are able to act as 
  “  co-agonists  ”   (  13  ). For CD4      T cells, stronger binding agonists 
were able to synergize with a larger fraction of endogenous 
suffi   cient time, even very low numbers of antigenic pMHC 
(in the presence of the low level of endogenous pMHC ex-
pressed on RMA-S cells) can be enough to stimulate the T cell. 
  The effect of nonstimulatory pMHC on antigen recognition 
is more pronounced with weaker agonists 
  Given the strong eff  ects of nonstimulatory peptides on recog-
nition of the strong agonist ligand OVA, we wondered whether 
nonstimulatory peptides would aff  ect recognition of weaker 
agonist altered peptide ligands (APLs). We found that the sin-
gle amino acid variants of OVA, Q4 and T4, were recognized 
by 25-D1.16, and therefore we could use these peptides simi-
larly to OVA. Q4 and T4 are both weaker agonists than OVA, 
with T4 being much weaker than Q4 (  23  ). Indeed, T4 is at the 
border between positive and negative selection in the thymus, 
and as such is one of the weakest ligands that in physiological 
circumstances would be expected to give a functional response 
upon recognition by the OT-I TCR. Up-regulation of the 
activation markers CD25 and CD69 on naive OT-I T cells by 
Q4 and T4 was delayed and required a higher peptide concen-
tration compared with OVA for stimulation (T4    Q4     OVA) 
(  Fig. 3, A and B  ).   When TCR down-  regulation was used as 
  Figure 2.     The effect of nonstimulatory peptides is most pro-
nounced at early time points. RMA-S cells were loaded with various 
amounts of OVA alone or OVA plus VSV. The RMA-S cells were allowed 
to interact with naive T cells for 2 (A), 7 (B), or 20 h (C). The cells were 
stained with anti-CD8 and anti-CD69, and the level of CD69 was assessed 
by fl  ow cytometry. The results are shown as percentage of CD69      cells 
from CD8 gated cells at different OVA-K  b   concentrations. The results are 
representative of four independent experiments.     
  Figure 3.     The effect of nonstimulatory peptides is increased with 
weaker agonists. RMA-S cells were loaded with various amounts of OVA, 
Q4 or T4 alone, or the same peptides plus VSV, respectively. The RMA-S 
cells were allowed to interact with naive T cells for 24 (A) or 5 h (B), or 
with effector cells for 3 h (C). The cells were stained with anti-CD8 in 
combination with anti-CD25 (A), anti-CD69 (B), or anti-V     2 (C), and the 
level of these molecules was assessed by fl  ow cytometry. The results are 
shown as percentage of CD25      (A) and percentage of CD69      (B) CD8 cells 
at different OVA, Q4, or T4-K  b   concentrations. The TCR down-regulation 
data (C) are shown as percentages of V     2 expression on the surface of 
CD8 cells incubated with RMA-S cells presenting different amounts of 
OVA, Q4, or T4-K  b   compared with cells incubated with RMA-S cells in the 
absence of an exogenously added peptide. The results are representative 
of four independent experiments.     JEM VOL. 204, October 29, 2007 
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  The effect of nonstimulatory peptides on antigen 
recognition depends on quantity but not quality of the 
nonstimulatory pMHC 
  To test whether diff  erent nonstimulatory peptides had a diff  er-
ent threshold for antigen recognition enhancement, we titrated 
the nonstimulatory peptides. For these experiments, the RMA-S 
cells were fi  rst loaded with antigen, which was then carefully 
washed away. The cells were divided into diff  erent groups into 
which the nonstimulatory peptides were titrated, followed by 
incubation and washing. This way we obtained cells that after 
incubation with diff  erent amounts of nonstimulatory peptides 
expressed the same amount of antigenic peptide (Fig. S1 and 
unpublished data). T cell sensitivity to antigen depended on 
the amount of nonstimulatory pMHC. The diff  erent nonstim-
ulatory peptides gave similar enhancement at similar cell sur-
face densities of K  b   (  Fig. 5  ).   Therefore, the ability of diff  erent 
nonstimulatory peptides to enhance antigen recognition in 
CD8      T cells depends on the quantity of nonstimulatory 
pMHC.   Fig. 5   also indicates that there were     550 endogenous 
K  b  -peptide molecules on the RMA-S cells. As this estimate 
derives from quantitative fl  ow cytometry using fl  uorescent 
beads (see Materials and methods), we believe this to be a more 
accurate estimate than the usually quoted number:     5% of 
perhaps 100,000 molecules on a parental RMA cell, therefore 
    5,000 molecules. Comparison of the number of CD69      cells 
after stimulation with RMA-S without added peptide and 
with those loaded with OVA only indicates that the endoge-
nous pMHC of the RMA-S cells did not have a measurable 
eff  ect on CD69 up-regulation in this assay. 
  Nonstimulatory peptides enhance effector functions 
of CD8     T cells 
  Next, we wanted to fi  nd out whether nonstimulatory pep-
tides are able to enhance eff  ector functions, such as cytokine 
production, in CD8      T cells. This was a particularly impor-
tant question because previous attempts by others had failed 
to show enhancement of eff  ector functions of CD8      T cells 
(  14  ). We measured IL-2 production of naive lymphocytes by 
intracellular cytokine staining after 5 h of incubation with 
peptide-loaded RMA-S cells. IL-2 expression was enhanced 
compared with OVA alone by the presence of a nonstimu-
latory peptide (  Fig. 6 A  ).   Similarly, IFN-      production of 
activated CTLs was increased in the presence of a nonstimu-
latory peptide (Fig. 6 B and Fig. S4, which is available at 
http://www.jem.org/cgi/content/full/jem.20062610/DC1). 
IL-2 expression was also enhanced by the nonstimulatory 
peptides in these cells (Fig. S5). To determine whether non-
stimulatory peptides enhance CTL killing of target cells as well, 
we assessed the infl  uence of nonstimulatory peptides during 
CTL killing of OVA and T4-labeled target cells. An enhanc-
ing eff  ect on cytotoxic activity (measured as survival of APCs 
after 17 h of coincubation with activated OT-I CTLs) was 
detectable for the weak agonist T4 but not for OVA (  Fig. 7  ).   
Therefore, endogenous or exogenous nonstimulatory peptides 
can enhance cytokine expression and the cytotoxic activity 
of CTLs. 
peptides compared with weaker binding agonists (  9, 13  ). 
Therefore, we wondered whether the universal ability of non-
stimulatory peptides to increase the sensitivity of CD8      T cell 
recognition in the presence of OVA-K  b   (  Fig. 1  ) was due to the 
comparatively high affi   nity interaction between OT-I TCR 
and OVA-K  b   (  24, 25  ). We tested the ability of several diff  erent 
nonstimulatory peptides to enhance antigen recognition of 
OVA (  Fig. 4 A  ), the weak agonist Q4 (  Fig. 4 B  ), the very weak 
agonist T4 (  Fig. 4 C  ), and a very weak agonist/antagonist G4 
(unpublished data).   Similarly to OVA, the recognition of each 
APL was enhanced in the presence of all the tested nonstimula-
tory peptides. Therefore, unlike CD4      T cells, the ability of 
diff  erent nonstimulatory peptides to enhance antigen recogni-
tion in CD8      T cells is not dependent on the quality of the 
nonstimulatory peptide. 
  Figure 4.     The ability of nonstimulatory peptides to enhance anti-
gen recognition is independent of the agonist strength. RMA-S cells 
were loaded with various amounts of OVA (A), Q4 (B), or T4 (C) alone or 
together with a nonstimulatory peptide. The RMA-S cells were allowed to 
interact with DP thymocytes for 5 h. The cells were stained with anti-CD8 
and anti-CD69, and the level of CD69 was assessed by fl  ow cytometry. 
The results are shown as percentage of CD69      CD8 gated cells at differ-
ent OVA, Q4, or T4-K  b   concentrations. The results are representative of at 
least two independent experiments.     2752 ENHANCEMENT OF T CELL ACTIVATION BY ENDOGENOUS   P  MHC | Yachi et al.
aff  ected by the nonstimulatory peptides (unpublished data). 
In conclusion, nonstimulatory peptides enhance eff  ector func-
tions in CD8      T cells. 
  Nonstimulatory peptides enhance formation and dissolution 
of T cell  –  APC conjugates 
  Next, we assessed whether the presence of nonstimulatory 
peptides and the resulting higher density of pMHC complexes 
on the APCs enhanced the formation of conjugates between 
T cells and APCs, and hence T cell activation by agonists. We 
incubated OT-I T cells with RMA-S cells, which had been 
loaded with OVA or T4, in the presence or absence of non-
stimulatory peptides. At various time points cells were pipet-
ted up and down to separate any weakly conjugated cells and 
fi  xed. Formation of conjugates between naive OT-I T cells 
and RMA-S cells was measured by fl  ow cytometry. For the 
strong agonist OVA, initial conjugate formation was enhanced 
if the nonstimulatory peptide was also present (  Fig. 8 A  ).   This 
eff  ect was seen for low amounts of OVA peptide and at early 
time points (up to 30 min of incubation; unpublished data). In 
the absence of added nonstimulatory peptides, the number of 
conjugates accumulated over time. However, this was not the 
case when nonstimulatory peptides were present. At later time 
points (     30 min), the number of conjugates for OVA plus 
nonstimulatory peptide was lower than for OVA alone (  Fig. 
8 B  ). For the weak ligand T4, nonstimulatory peptides increased 
the number of conjugates even at later time points (  Fig. 8 B  ). 
  We conclude from these experiments that the co-presenta-
tion of nonstimulatory peptides favors not only the initial con-
jugate formation but, as observed for the strong agonist OVA, 
also shortens the interaction time of T cells and APCs required 
for T cell activation. As a result, the T cells dissociate faster. 
    DISCUSSION   
  In this work we have shown that nonstimulatory peptides en-
hance antigen recognition as measured by eff  ector functions, 
such as cytokine production and CTL killing, by inducing 
  In addition to CD69 and CD25, we measured the eff  ect of 
nonstimulatory peptides on several other phenotypic markers, 
such as CD5, CD44 (on naive cells), and HSA, which were all 
  Figure 5.     The effect of nonstimulatory peptides on antigen rec-
ognition depends on quantity but not quality of the nonstimulatory 
pMHC. RMA-S cells were loaded with OVA peptide, washed, and ali-
quoted to different groups. Nonstimulatory peptides were titrated on the 
antigen-loaded cells and, after incubation, washed away. The cells were 
allowed to interact with DP thymocytes for 2 h. The cells were stained 
with anti-CD8 and anti-CD69, and the level of CD69 was assessed by 
fl  ow cytometry. The results are shown as percentage of CD69      CD8  gated 
cells in the presence of different numbers of K  b   molecules. The effect of 
the nonstimulatory peptides without any OVA is shown surrounded by a 
box, but using the same symbols as for those with added OVA. The re-
sults are representative of at least three independent experiments. Fig. S1 
shows histograms of CD69 up-regulation by RMA-S cells matched for 
low expression of OVA-K  b   in the presence or absence of excess nonstim-
ulatory peptide-K  b .   
  Figure 6.     Nonstimulatory peptides enhance cytokine production. 
RMA-S cells were loaded with various amounts of OVA alone or together 
with VSV. The RMA-S cells were allowed to interact with naive T cells 
(A) or effector cells (B) for 5 h (A and B). The cells were fi  rst stained with 
anti-CD8, and then intracellularly with anti  –  IL-2 (A) or anti  –  IFN-      (B),  and 
the cytokine level was assessed by fl  ow cytometry. The results are shown 
as percentage of cytokine      cells at different OVA-K  b   concentrations.  The 
results are representative of eight independent experiments.     
  Figure 7.     Nonstimulatory peptides enhance CTL killing of target 
cells. RMA-S cells were loaded with various amounts of OVA or T4 alone 
or together with VSV. The Cy5-labeled RMA-S cells were allowed to inter-
act with effector cells for 17 h. Cell death was determined by death-
associated changes in the forward- and side-scatter properties among the 
RMA-S cell population (Cy5     ). Results are shown as percentage of live 
RMA-S cells for different OVA or T4-K  b   concentrations and are represen-
tative of four independent experiments.     JEM VOL. 204, October 29, 2007 
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peptides (    550 K  b   molecules in our experiments) (  Fig. 5  ). 
RMA-S is a mutant subline of RMA, and has therefore been 
separated from RMA by many passages. RMA-S could there-
fore potentially have other diff  erences to RMA than simply the 
lack of Tap2 protein. Our experiments used the same RMA-S 
cells to compare the eff  ect of presence or absence of added 
nonstimulatory peptides on antigen recognition, and therefore 
the two groups were identical in all respects except for the 
presence of nonstimulatory pMHC. In addition, we compared 
RMA-S to RMA cells, and in contrast to Sporri, found that 
RMA induced a better response to antigen than did RMA-S 
(Fig. S3). RMA has a slightly higher K  b   expression than the 
maximum expression that we reached on RMA-S with added 
peptides (unpublished data). Another diff  erence between the 
studies is that Sporri and Reis e Sousa irradiated the APCs. 
However, this did not explain the diff  ering results (unpublished 
data), which are most likely due to diff  ering sensitivities of the 
assays used, with the relatively few endogenous peptides pres-
ent in RMA-S cells suffi   cient to induce some responses, partic-
ularly that of CTL to strong agonist (  Fig. 7   and reference   14  ). 
  We have shown that nonstimulatory peptides are most im-
portant in antigen recognition by less diff  erentiated cells, such 
that their ability to enhance antigen recognition is most evi-
dent in thymocytes, moderate in naive T cells, and mild in 
eff  ector T cells. The diff  erent time courses of nonstimulatory 
peptide contribution to antigen recognition also underline the 
developmental diff  erences in the importance of nonstimula-
tory peptides in antigen recognition. This fi  ts well with data 
showing that DP thymocytes respond better to pMHC than 
anti-CD3 mAb activation as compared with naive T cells (  26  ). 
Evidence indicates that immature thymocytes are more sensi-
tive to low affi   nity ligands than mature T cells, but that both 
respond well to high affi   nity ligands (  26, 27  ). The sensitivity of 
immature thymocytes was recently correlated to miR-181a 
expression levels, which in part aff  ects phosphatases and there-
fore aff  ects the threshold of TCR signaling (  28  ). Low affi   nity 
ligands are generally more CD8 dependent (  29  ). This devel-
opmental dependence may be due to higher CD8-MHC 
avidity in thymocytes caused by diff  erential glycosylation (  30  ). 
In addition, immature thymocytes express 10-fold less TCR 
compared with mature T cells (  31  ). Therefore, due to higher 
affi   nity and a higher ratio of CD8 to TCR in immature thy-
mocytes, pMHC binding to CD8 is more prominent in thy-
mocytes compared with mature T cells. Alternatively, cells at 
diff  erent stages of development may have diff  erent membrane 
compartmentalization of TCR and CD8 and their associated 
molecules such as Lck that might aff  ect their ability to take 
advantage of nonstimulatory peptides during antigen recogni-
tion. The more mature cells are also more sensitive to minute 
amounts of peptides in the absence of added nonstimulatory 
peptides (  Fig. 1  ), so they may simply not be as reliant on non-
stimulatory pMHC because they have other means such as ad-
hesion and costimulatory molecules to enhance their sensitivity 
to antigen, or they may be sensitive enough to make use of the 
relatively few endogenous pMHC complexes present in the 
RMA-S cells. In addition, activated T cells were shown to 
phenotypic maturation of the T cells, such as up-regulation 
of CD25, CD69, CD44, CD5, and HSA expression, and by 
the number of TCRs stimulated, as measured by TCR down-
modulation. With the strong agonist OVA we saw enhance-
ment of T cell  –  APC conjugate formation at early time points 
when nonstimulatory pMHC was available, but at later time 
points there was a decrease in the number of conjugates com-
pared with the cells in the absence of nonstimulatory peptide. 
These results indicate that nonstimulatory peptides do not just 
simply enhance adhesion between cells but that they allow the 
T cell activation program to proceed faster, leading to earlier 
dissociation of the conjugates in the presence of nonstimulatory 
peptides. This would allow a more robust immune response, 
as T cells would be able to change their polarization status for 
cytokine production, proliferation, diff  erentiation, killing of the 
next target, and homing to target organs, for example. For the 
weak agonist T4, the conjugates were increased in the pres-
ence of a nonstimulatory peptide even at 60 min, refl  ecting the 
lower and slower capability of T4 to execute the full signaling 
program needed to terminate the cell contact. 
  In contrast to our work (10 and this work) and that of oth-
ers (  11  ), an earlier study did not support an enhancing role for 
self-pMHC class I complexes in CD8      T cell antigen recogni-
tion (  14  ). This is particularly surprising in that Sporri and Reis 
e Sousa performed a similar experiment to us, comparing stim-
ulation by RMA cells, which express endogenous peptides, 
versus RMA-S cells, which express relatively few endogenous 
  Figure 8.     Nonstimulatory peptides affect duration of T  –  APC conju-
gates. RMA-S cells were labeled with Cy5 and loaded with various 
amounts of OVA or T4 alone or together with VSV. The RMA-S cells were 
allowed to interact with naive T cells for the indicated times. The cells were 
fi  xed and stained for CD8, and cell conjugate formation was assessed by 
fl  ow cytometry based on simultaneous staining for CD8 and Cy5. Results 
are shown as percentage of cell conjugates among CD8 cells for different 
OVA or T4-K  b   concentrations at 20- (A) and 60-min (B) time points. The 
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pseudodimer (  9, 12  ). Only certain endogenous pMHC com-
plexes were shown to synergize with agonist, suggesting that 
TCR binding to the endogenous pMHC is important (  9  ). 
This does not seem to be the case for CD8      T cells, as all the 
peptides tested were able to aid antigen recognition. There-
fore, as a mechanism of synergism by nonstimulatory peptides 
in antigen recognition by CD8      T cells, we proposed a pre-
concentration model, in which noncognate interactions be-
tween CD8 and MHC concentrate CD8, its associated Lck, 
and pMHC complexes to the synapse, thus aiding the TCR to 
fi  nd its ligand and allowing easier access and a high concentra-
tion of CD8-Lck to enhance signal transduction (  10  ). Pre-
concentration could potentially change the quality of the 
signal received by T cells, as we found that recognition of 
APLs is translated to diff  erent CD8  –  TCR interaction kinetics, 
such that the interaction is induced faster for stronger ligands 
(  37  ). Therefore, pre-concentration of CD8 could speed up 
the antigen-induced interaction between CD8 and TCR, 
leading to signaling characteristic of a stronger agonist than in 
the absence of endogenous peptides. This notion is supported 
by the fi  nding that thymocytes respond better to low affi   nity 
ligands than do mature T cells (  26  ), by our data showing that 
thymocytes are the most effi   cient at taking advantage of non-
stimulatory peptides (  Fig. 1  ), and that nonstimulatory peptides 
are most important in recognition of weaker ligands (  Fig. 3  ). 
  The diff  ering results obtained with CD4      and CD8      
T cells may in part be due to diff  erences in methods. In the 
CD8      T cell system we have used RMA-S cells to present 
the pMHC complexes, whereas in the CD4      T cell system 
Krogsgaard et al. (  9  ) used soluble pMHC heterodimers. These 
soluble heterodimers are well defi  ned in regards to their pMHC 
content, consisting of one agonist and one nonstimulatory 
peptide, allowing precise control of stimulation. RMA-S cells 
have the caveat that they do express a few percentages of 
endogenous pMHC complexes compared with physiological 
levels (  18  –  20  ), and therefore in our RMA-S system we have 
several hundred endogenous pMHC molecules as a background. 
We have described above why these do not pose a problem 
for our major conclusions. Soluble pMHC heterodimers have 
their own caveats, for example, that the ratio of antigen to 
nonstimulatory peptide is 1:1. In a natural antigen-presenting 
environment the ratio of endogenous pMHC to antigenic 
pMHC is enormous. RMA-S is therefore more useful in 
approximating this situation, which is highly relevant to our 
proposed pre-concentration model. It is also possible that the 
lack of an APC surface could be important in experiments with 
oligomers, perhaps for correct alignment of the molecules 
relative to each other, whereas this would not be a problem for 
RMA-S studies. Clearly there are advantages and disadvantages 
to both methods, and it will be important to use diff  erent 
methods to truly elucidate all the layers of endogenous pep-
tide participation in antigen recognition. 
  Another possibility is that the diff  erence between CD4      
and CD8      cells is that the higher affi   nity of CD8 rather than 
CD4 for noncognate pMHC (38) overcomes and obscures 
the requirement for the TCR interaction with endogenous 
have 20  –  50 times higher TCR avidity for pMHC complexes 
as compared with naive T cells, a fi  nding that was linked to 
TCR reorganization and cholesterol content (  32  ). 
  T cells have been shown to form organized structures 
called IS between T cells and APCs. Although the exact func-
tion of the IS remains elusive, it has been proposed to act in sig-
nal integration. In particular, modeling studies suggested that 
formation of central supramolecular activation cluster (cSMAC) 
enhances weak signals by concentrating TCR, pMHC, and 
Lck while dampening strong signals by enhancing TCR deg-
radation (  33  ). The organization of the IS diff  ers depending on 
the state of T cell diff  erentiation, and this may contribute to 
diff  erent abilities of nonstimulatory peptides to enhance anti-
gen recognition at diff  erent states of diff  erentiation. Recent 
data using total internal refl  ection fl  uorescence microscopy 
indicate that TCR signaling occurs in microclusters in the pe-
riphery of the synapse (  34  ), suggesting that the main function 
of cSMAC is to down-regulate signaling. This is supported by 
a recent paper showing that the stimulatory potency of a pep-
tide was reduced when cSMAC formation was increased (  35  ). 
However, this may not be the case with weaker agonists or in 
physiological circumstances where antigen is limiting. Our 
fi  nding that the ability of nonstimulatory peptides to enhance 
antigen recognition is more pronounced with weaker agonists, 
and at lower antigen concentrations, would support a role 
for nonstimulatory peptides in clustering key molecules for 
enhanced antigen recognition. 
  In CTL assays, nonstimulatory peptide did not seem to 
play a major role when presented with OVA. However, the 
sensitivity of OVA-K  b   staining by the 25-D1.16 antibody is 
not suffi   cient to identify the very small number of ligands that 
are suffi   cient to mediate killing by CTLs (  12, 36  ), so it is possible 
that at such low levels of peptide nonstimulatory peptides 
are important. Alternatively, the relatively few endogenous 
pMHC complexes present on RMA-S may have been suffi   -
cient to help recognition of the strong agonist by CTLs, even 
though this was not evident in other assays. For the very weak 
agonist peptide T4, which requires higher amounts of peptide 
to induce a response, and therefore where minimally stimulatory 
concentrations of T4-K  b   fall within the limits of 25-D1.16 
resolution, we saw increased killing in the presence of non-
stimulatory peptides. 
  All the nonstimulatory endogenous (or exogenous) pep-
tides that we have tested were able to aid in antigen recogni-
tion by CD8      T cells, and their eff  ect was more evident in 
recognition of weaker ligands. This is in contrast to CD4      
T cells where only certain endogenous peptides acted to en-
hance recognition by agonist, and their ability to function was 
dependent on the strength of the agonist; stronger agonists 
were helped by a larger proportion of endogenous peptides 
than weaker agonists (  9, 13  ). This suggests that there is a pro-
nounced diff  erence between CD8      and CD4      T cells in their 
ability to take advantage of endogenous nonstimulatory pep-
tides. It has been suggested (for CD4      T cells) that two TCRs 
binding, respectively, to agonist and endogenous pMHC 
complexes, are bridged by the coreceptor CD4 to form a JEM VOL. 204, October 29, 2007 
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once. For OVA, Q4 or T4-K  b   quantitation RMA-S cells were stained with 
25-D1.16 antibody together with PE-conjugated Fab goat anti  –  mouse IgG. 
The total pMHC was quantitated with PE-labeled K  b  -specifi  c  antibody 
(AF6-88.5). The QuantiBRITE phycoerythrin fl  uorescence quantitation kit 
(Becton Dickinson) was used to calculate the number of molecules. 
  Preparation of T cells.     Pre-positive selection thymocytes, CD4     CD8      
DP thymocytes, were isolated from OT-I Tap       /       mice. Naive OT-I T cells 
were prepared from pooled lymph nodes of 6  –  12-wk-old OT-I mice. Acti-
vated T cells were generated by antigen-specifi  c stimulation of naive OT-I 
T cells. In brief, pooled OT-I lymph node cells (2.5   ×   10  6   cells) were seeded 
in 24-well plates and stimulated with irradiated OVA-loaded C57BL/6J 
spleen cells (3   ×   10  6   cells) in RPMI complete medium supplemented with 
rat Con A supernatant at a fi  nal concentration of 5% (vol/vol). Fresh medium 
containing 2% of rat Con A supernatant was added at days 2 and 4. T cell 
cultures were used as eff  ector cells on day 6 after antigen stimulation. 
  T cell activation assays.     T cells (2  –  3   ×   10  5   cells in 50      l) were incubated 
with peptide-pulsed RMA-S cells (10  5   cells in 20      l) in round-bottom 
96-well plates at 37  °  for the indicated times, and the T cell activation status 
was measured as described below. 
  Antibody staining and fl  ow cytometric analysis.     After incubation, cells 
were stained for CD8, CD69, and CD25 or V     2 in FACS buff  er (0.02% 
azide, 10% FCS in PBS) and washed, and the samples were run on a fl  ow 
cytometer. For FACS analysis, T cells were gated according to the appropriate 
scatter profi  le and CD8 expression. To avoid unspecifi  c APC background, 
RMA-S  –  T cell conjugates were excluded based on simultaneous staining for 
CD8 and Cy5 (Cy5-labeled RMA-S cells) and their forward- and side-scat-
ter profi  le. The TCR down-regulation data are shown as a percentage of 
V     2 expression on the surface of cells compared with cells incubated with 
RMA-S cells in the absence of an exogenously added peptide. For CD69 and 
CD25 up-regulation, the percentage of CD8      T cells expressing CD69  high   
and CD25  high   population is presented. The gate defi  ning CD69 or CD25  low   
versus CD69 or CD25  high   was determined from corresponding samples in 
which T cells were incubated with nonpeptide-pulsed RMA-S cells. 
  Cell conjugate assay.     For the conjugate assay, cells were pipetted up and 
down three times at the indicated time points to separate any weakly conju-
gated cells and fi  xed in 4% paraformaldehyde. Paraformaldehyde was inacti-
vated by 10 mM Tris, pH 7.4, in PBS. Cells were washed in PBS and stained 
with anti-CD8 antibody. Cell conjugates were analyzed by fl  ow cytometry 
based on simultaneous expression of CD8 (CD8 antibody staining) and Cy5 
(Cy5-labeled RMA-S cell). 
  Cytotoxicity assay.     To determine T cell  –  mediated cytotoxicity, T cells 
and RMA-S cells were incubated for 17 h. After incubation, cells were 
stained for CD8. Cell death was determined by death-associated changes in 
the forward- and side-scatter properties among the Cy5      (CD8        ) RMA-S 
cell population. 
  Intracellular cytokine staining.     For intracellular IL-2/IFN-      staining, 
T cells and RMA-S cells (Cy5-labeled) were incubated in the presence of 
0.67      g/ml Monensin (GolgiStop; BD Biosciences) to block the release of cyto-
kines from the cells. After incubation, cells were stained for CD8 and then fi  xed 
with 4% paraformaldehyde. After inactivation of paraformaldehyde with 10 mM 
Tris, pH 7.4, in PBS, the cells were washed in FACS buff  er and permeabilized 
in FACS buff  er containing 0.2% saponin. Subsequent staining for IL-2 or IFN-      
and washing were performed in FACS buff  er containing 0.2% saponin. Cells 
were analyzed by fl  ow cytometry. IL-2      and IFN-           cells were determined 
among CD8      T cells, excluding APCs, by cell size and Cy5 staining. 
  Online supplemental material.     Fig. S1 shows example histograms for K  b  
and K  b -OVA expression on RMA-S cells treated with OVA peptide with 
or without excess nonstimulatory VSV peptide, plus the up-regulation 
pMHC that is seen in the class II  –  restricted system. Thus, all 
of the endogenous pMHC complexes work in the class I sys-
tem, even with weak agonists like Q4, T4, and G4. Indeed, 
Q4 and T4 have tetramer-binding avidities close to that of the 
noncognate CD8  –  MHC class I avidity (  23  ). In addition to our 
data showing that the noncognate CD8  –  pMHC interaction 
concentrates these molecules at the IS and may therefore ex-
plain the role of any of the nonstimulatory pMHC complexes 
in aiding antigen recognition (  10  ), recent data show a domi-
nant eff  ect of the noncognate CD8  –  pMHC interaction in en-
hancing TCR recognition (  11  ), and that the CD8  –  pMHC 
interaction precedes the TCR  –  pMHC interaction (  39  ). These 
data support the idea (pre-concentration model) that the non-
cognate interaction of CD8 with class I is responsible for the 
eff  ect of the nonstimulatory peptides. 
  In summary, we have shown that nonstimulatory peptides 
universally lower the threshold for antigen recognition, an 
eff  ect measurable at many diff  erent levels. This eff  ect is more 
important for weaker agonists and is fi  ne-tuned depending on 
the diff  erentiation status of the T cell. 
  MATERIALS AND METHODS 
  Peptides and antibodies.     Peptides OVA (SIINFEKL), VSV (RGYVY-
QGL), Q4 (SIIQFEKL), G4 (SIIGFEKL), and T4 (SIITFEKL) were gener-
ated at the Protein and Nucleic Acid Core Facility at The Scripps Research 
Institute and purifi  ed by HPLC. P815 (HIYEFPQL), Mapk1  (19  –  26)   (amino 
acid range in parentheses; VGPRYTNL), STAT3  (53  –  60)   (ATLVFHNL), 
Ndufa4  (61  –  68)   (VNVDYSKL), Slc2a3  (314  –  321)   (VNTIFTVV), and Hcph  (503  –  510)   
(AQYKFIYV) were provided by S. Jameson (University of Minnesota, 
Minneapolis, MN). Antibodies used in this study were PE-conjugated Fab 
goat anti  –  mouse IgG (Protos Immunoresearch) and H2-K  b   OVA-specifi  c 
25-D1.16 (provided by R. Germain, National Institutes of Health [NIH], 
Bethesda, MD). Anti-CD8      (clone H35-17.2), anti-K  b   (clone AF6-88.5), anti-
CD8      (53  –  6.7), anti-CD69 (H1.2F3), anti-CD25 (PC61), anti-V     2(B20.1), 
and anti  –  IFN-      (XMG1.2) were obtained from BD Biosciences. Anti-CD8 
(CT-CD8     ) from Caltag/Invitrogen was used for staining of fi  xed cell con-
jugates. Anti  –  IL-2 (JES6-5H4) was from eBioscience. 
  Mice.     C57BL/6J (B6) mice were bred and maintained at The Scripps 
Research Institute. OT-I mice bearing a transgenic TCR specifi  c for OVA-K  b   
(V     2, V     5) (  16  ) and OT-I mice defi  cient for   Tap1   (OT-I   Tap1   KO) (  15  ) 
were obtained from S. Jameson and K. Hogquist (University of Minnesota, 
Minneapolis, MN). All mice were maintained at The Scripps Research Insti-
tute, and all experiments were performed in accordance with the guidelines 
of the Animal Care and Use Committee of The Scripps Research Institute. 
  APC preparation.       Tap2  -defective RMA-S cells that are defective in bind-
ing endogenous peptides to newly synthesized MHC class I molecules (  18  ) 
were used as APCs. Stable expression of K  b   or D  b   can be achieved by adding 
synthetic peptides able to bind to K  b   or D  b   exogenously to the cell culture 
(  19, 20  ). The RMA-S cells were maintained in RPMI medium containing 
10% FCS, 2 mM   l  -glutamine, 100 U/ml penicillin/streptomycin, and 
50      M      -mercaptoethanol. RMA-S cells were stained with Cy5 20 h before 
experiments by incubating cells with 0.1 mg/ml of Cy5 monomeric succin-
imidyl ester (GE Healthcare) in RPMI at room temperature for 5 min, wash-
ing with RPMI, and quenching with 10% FCS in RPMI. Diff  erent peptides 
have a diff  erent ability to stabilize pMHC, and the diff  erent nonstimulatory 
peptides were titrated to give comparable cell surface pMHC quantity. The 
peptide amounts added to the culture were as follows: 80      M VSV, 28      M 
P815, 36      M Mapk1, 9      M Ndufa4, 15.8      M Hcph, 19.5      M Slc2a3, and 
27      M STAT3. The RMA-S cells were incubated at 29  °  C overnight, pulsed 
with peptides for 30 min at 29  °  C, incubated at 37  °  C for 3 h, and washed 2756 ENHANCEMENT OF T CELL ACTIVATION BY ENDOGENOUS   P  MHC | Yachi et al.
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of CD69 expression on naive OT-I T cells induced by these RMA-S cells. 
Fig. S2 shows the eff  ect of nonstimulatory peptides on up-regulating 
CD69 on activated T cells or preselection DP thymocytes at diff  erent time 
points. Fig. S3 shows a comparison of CD69 up-regulation on naive OT-I 
T cells in response to RMA or RMA-S cells presenting antigen. Fig. S4 
shows that nonstimulatory peptides enhance IFN-      expression in eff  ector 
T cells responding to antigen. Fig. S5 shows that nonstimulatory peptides 
enhance IL-2 expression in eff  ector T cells in response to antigen. The 
online supplemental material is available at http://www.jem.org/cgi/content/
full/jem.20062610/DC1. 
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